Familial Nasopharyngeal Carcinoma 6

40 Q-T. Le and J. J. LuPan J, Kong L, Lin S, et al (2008) The clinical significance of coexpressionof cyclooxygenases-2, vascular endothelial growthfactors, and epidermal growth factor receptor in nasopharyngealcarcinoma. Laryngoscope 118:1970–1975Pedersen MW, Meltorn M, Damstrup L, et al (2001) The typeIII epidermal growth factor receptor mutation. Biologicalsignificance and potential target for anti-cancer therapy.Ann Oncol 12:745–760Pepper MS, Ferrara N, Orci L, et al (1991) Vascular endothelialgrowth factor (VEGF) induces plasminogen activators andplasminogen activator inhibitor-1 in microvascular endothelialcells. Biochem Biophys Res Commun 181: 902–906Qian CN, Zhang CQ, Guo X, et al (2000) Elevation of serum vascularendothelial growth factor in male patients with metastaticnasopharyngeal carcinoma. Cancer 88:255–61Ren Q, Sato H, Murono S, et al (2004) Epstein–Barr virus (EBV)latent membrane protein 1 induces interleukin-8 throughthe nuclear factor-kappa B signaling pathway in EBVinfectednasopharyngeal carcinoma cell line. Laryngoscope114:855–859Risau W (1997) Mechanisms of angiogenesis. Nature 386(6626):671–674Schwentner I, Witsch-Baumgartner M, Sprinzl GM, et al (2008)Identification of the rare EGFR mutation p.G796S as somaticand germline mutation in white patients with squamous cellcarcinoma of the head and neck. Head Neck 30:1040–1044Seiwert TY, Haraf DJ, Cohen EE, et al (2008) Phase I study ofbevacizumab added to fluorouracil- and hydroxyureabasedconcomitant chemoradiotherapy for poor-prognosishead and neck cancer. J Clin Oncol 26:1732–1741Sengupta S, den Boon JA, Chen IH, et al (2008) MicroRNA 29cis down-regulated in nasopharyngeal carcinomas, upregulatingmRNAs encoding extracellular matrix proteins.Proc Natl Acad Sci U S A 105:5874–5878Sheen TS, Huang YT, Chang YL, et al (1999) Epstein–Barrvirus-encoded latent membrane protein 1 co-expresseswith epidermal growth factor receptor in nasopharyngealcarcinoma. Jpn J Cancer Res 90:1285–1292Shi W, Bastianutto C, Li A, Perez-Ordonez B, et al (2006)Multiple dysregulated pathways in nasopharyngeal carcinomarevealed by gene expression profiling. Int J Cancer119:2467–2475Singh AB, Harris RC (2005) Autocrine, paracrine and juxtacrinesignaling by EGFR ligands. Cell Signal 17: 1183–1193Sok JC, Coppelli FM, Thomas SM, et al (2006) Mutant epidermalgrowth factor receptor (EGFRvIII) contributes to headand neck cancer growth and resistance to EGFR targeting.Clin Cancer Res 12:5064–5073Soo R, Putti T, Tao Q, et al (2005) Overexpression of cyclooxygenase-2in nasopharyngeal carcinoma and associationwith epidermal growth factor receptor expression. ArchOtolaryngol Head Neck Surg 131:147–152Sriuranpong V, Mutirangura A, Gillespie JW, et al (2004) Globalgene expression profile of nasopharyngeal carcinoma bylaser capture microdissection and complementary DNAmicroarrays. Clin Cancer Res 10:4944–4958Stacker SA, Caesar C, Baldwin ME, et al (2001) VEGF-D promotesthe metastatic spread of tumor cells via the lymphatics.Nat Med 7:186–191Stefani G, Slack FJ (2008) Small non-coding RNAs in animaldevelopment. Nat Rev Mol Cell Biol 9:219–230Sung FL, Poon TC, Hui EP, et al (2005) Antitumor effect andenhancement of cytotoxic drug activity by cetuximab innasopharyngeal carcinoma cells. In Vivo 19: 237–245Swaminathan S (2008) Noncoding RNAs produced by oncogenichuman herpesviruses. J cell physiol 216:321–6Verheul HM, Pinedo HM (2007) Possible molecular mechanismsinvolved in the toxicity of angiogenesis inhibition.Nat Rev Cancer 475–485Vermorken JB, Mesia R, Rivera F, et al (2008) Platinum-basedchemotherapy plus cetuximab in head and neck cancer. NEngl J Med 359:1116–1127Vokes EE, Chu E (2006) Anti-EGFR therapies: clinical experiencein colorectal, lung, and head and neck cancers.Oncology (Williston Park) 20:15–25Volante M, Saviozzi S, Rapa I, et al (2007) Epidermal growthfactor ligand/receptor loop and downstream signaling activationpattern in completely resected nonsmall cell lungcancer. Cancer 110:1321–1328Wakisaka N, Wen QH, Yoshizaki T, et al (1999) Association ofvascular endothelial growth factor expression with angiogenesisand lymph node metastasis in nasopharyngeal carcinoma.Laryngoscope 109:810–814Yarden Y (2001a) The EGFR family and its ligands in humancancer. signalling mechanisms and therapeutic opportunities.Eur J Cancer 37:S3–8Yarden Y, Sliwkowski MX (2001b) Untangling the ErbB signallingnetwork. at Rev Mol Cell Biol 2:127–137Zeng ZY, Zhou YH, Zhang WL, et al (2007) Gene expressionprofiling of nasopharyngeal carcinoma reveals the abnormallyregulated Wnt signaling pathway. Hum Pathol 38:120–133Zheng X, Hu L, Chen F, et al (1994) Expression of Ki67 antigen,epidermal growth factor receptor and Epstein–Barr virusencodedlatent membrane protein (LMP1) in nasopha ryngealcarcinoma. Eur J Cancer B Oral Oncol 30B:290–295